Pacira BioSciences, Inc. PCRX Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfShortTermInvestments.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s investment proceeds?
- Pacira BioSciences, Inc. (PCRX) reported investment proceeds of $22.5M in Q1 2026.
- How has Pacira BioSciences, Inc.'s investment proceeds changed year-over-year?
- Pacira BioSciences, Inc.'s investment proceeds decreased by 67.5% year-over-year, from $69.25M to $22.5M.
- What is the long-term trend for Pacira BioSciences, Inc.'s investment proceeds?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s investment proceeds has grown at a -28.9% compound annual growth rate (CAGR), from $1.07B to $273.81M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.